wall relaxation (24 cases), respectively. In conclusion, ECG and echocardiographic alterations coherent with Chagas cardiomyopathy were found in a large proportion of newly diagnosed Latin American migrants infected with T. cruzi. In the mid-term, Chagas disease might become an important cause of chronic cadiomyopathy in our attendance area.
Following Latin American migration, Chagas disease has inevitably appeared in non-endemic countries in Europe and elsewhere. New policies are necessary to prevent transmission in those countries but the long, often undetected chronic period of the early stages of the disease also renders epidemiological studies important. The main objective of our study was to determine the presence of clinical, electrocardiogram (ECG) and echocardiographic abnormalities in a population of Latin American migrants infected with Trypanosoma cruzi at the moment of diagnosis. We performed a hospital-based observational study of 100 adult patients with newly diagnosed Chagas infection between January 2005 and December 2009. Thirtyseven patients were classified within the Brazilian Consensus on Chagas cardiomyopathy early cardiac stages (A or B1) and 49 presented pathological findings (stage B2) according to the Panamerican Health Organization Classification. Overall, 49 patients showed ECG and/or echocardiographic alterations. The presence of ECG and ecocardiographic alterations were significantly associated (p=0.038). The most frequent ECG and echocardiographic findings were right bundle branch block (12 cases) and impaired left ventricular
Introduction
Chagas disease is a zoonosis caused by the parasite Trypanosoma cruzi, a flagellated protozoa mainly transmitted to humans by the faeces of blood-sucking triatomine bugs (Triatoma infestans and others). A hundred years from its description, Chagas disease remains a neglected tropical disease and is as such recognised by the World Health Organization [1] . Until the late twentieth century, Chagas had a geographical distribution that was confined to that of its vector, namely in Central and South America. Today, the disease is no longer confined to Central and South America. Non-endemic countries in Europe and elsewhere have seen the emergence of Chagas disease following migration of chronically infected individuals from endemic areas. In Europe, for example, there are an estimated 2,300,000 Latin American migrants, both documented or undocumented [2, 3] and non-endemic countries need to consider implementing preventive policies concerning blood transfusion, organ transplantation and vertical transmission [4, 5] .
Acute Chagas disease manifests clinically with fever and lyphadenopathy, unspecific general malaise and is self-limiting. It is followed by a long asymptomatic period of latency (or chronic disease) characterised by the presence of antibodies against Trypanosoma cruzi. In this stage, clinical examination of the chest, oesophagus and colon may be normal, the 12-lead electrocardiogram (ECG) can show no irregularities or minor alterations. After decades of undetected, asymptomatic disease, over 40% of infected individuals develop clinical symptoms reflecting the tissue damage. They usually involve the heart or digestive tract. The clinical outcome of the chronic phase of Chagas disease ranges from the absence of sings and symptoms to sudden premature deaths due to silent severe cardiomyopathy. Classically it is considered that up to a 30% of those infected will develop cardiac symptoms or ECG alterations within 10-30 years after the initial infection [6] .
Although the pathogenesis of Chagas is not completely understood, a growing consensus points to a combination of direct tissue effects of the parasite with an immunologic response that may paradoxically increase the tissue inflammation and thus over time lead to fibrosis [7] . Such low-intensity inflammation causes the specific Chagas cardiomyopathy and sooner or later affects the conduction system. This affection is reason for the often pathological ECG findings in Chagas patients [8] . Chagas cardiomyopathy marks the prognosis of the disease. It results in impairment of contractile function and final dilation of all four heart chambers. Eventually, ventricular tachycardia or refractory congestive heart failure threaten the lives of those affected [9] .
Spain has become the main European destination of Latin migration in recent decades [10] . We undertook a hospital-based descriptive study to determine the presence of cardiac (clinical, ECG and echocardiographic) alterations in of a population of infected Latin American migrants at the moment of the diagnosis as well as to estimate their clinical and functional cardiac staging.
Methods
Between January 2005 and December 2009, we studied all consecutive adult patients newly diagnosed with Chagas infection at the Unitat de Salut Internacional Metropolitana Nord. The Unitat de Salut is a referral unit shared by the Primary Care Service and the tertiary care Hospital Universitari Germans Trias i Pujol. Both are located in the Barcelona Metropolitan Area, Spain; they serve a population of over two million people of which approximately 6% are Latin American migrants. The unit belongs to the Institut Català de la Salut, the main public health provider in Catalonia and, therefore, the medical visits were free of charge. The majority of patients were referred by family practitioners as foreseen in the protocol of the Chagas screening program for populations at risk (i.e. Latin American pregnant women, Bolivian natives, other Latin American migrants with any risk factor for Chagas disease) at primary care level in Catalonia [11] .
Exclusion criteria for the study were: (i) documented previous diagnose of Chagas infection or antichagasic treatment, (ii) age less than 15 years, (iii) presence of hypertension, diabetes, coronary artery disease or other concurrent diseases associated with cardiomyopathy and, (iv) pregnancy.
Individuals were considered as Chagas cases when two commercialised enzyme-linked immuno sorbent assay (ELISA)-based serological tests against crude and recombinant T. cruzi antigens, were positive. In case of discrepant results, a third test, based on indirect immunoflourescence (IIF) was performed.
All newly-diagnosed Chagas patients underwent a clinical evaluation, including full medical history, physical examination, ECG with 30 seconds DII strip and a twodimensional and Doppler echocardiography.
The following variables were assessed: age, sex, country of origin and having lived in rural environment (yes/ no), previous adobe housing (yes/no) self-reported family history of Chagas infection (yes/no), mother with Chagas infection (yes/no), cardiac symptoms, ECG alterations, echocardiographic abnormalities, debut as acute cardiac event (i.e. tachyarrythmia, cardiac syncope, pulmonary or systemic tromboembolism and acute heart failure) and Chagas cardiomyopathy staging.
The variable "cardiac symptoms", assessed as a dichotomy variable (yes/no) included at least one of the following features: antecedents of chest pain, palpitations, syncope, pulmonary thromboembolism, stroke and symptoms of heart failure such as oedema of the lower legs or dyspnoea on exertion.
The ECG alterations assessed were: sinus bradycardia, right bundle branch block, left anterior fascicular block, left bundle branch block, posterior fascicular block, atrial fibrillation, any degree of atrioventricular block, ventricular extrasystoles and Q wave or diffuse ST-T changes presence. The echocardiographic alterations assessed were: left ventricular wall dysfunction, ventricular aneurysm (apical or other), low ejection fraction (if <50%) and valve disease attributable to Chagas endocardial fibrosis.
For the Chagas cardiomyopathy staging we used the Brazilian Consensus [12] and the recent Panamerican Health Organization Classification of Chagas cardiomyopathy [13] (Figure 1 ). The Brazilian Consensus classification categorises "left ventricular low ejection fraction" according to data based on echocardiographic outcomes (Figure 1 ).
The relative frequency of the variables and their association with socio-demographic (age, sex, family history and mother with Chagas infection) or setting characteristics (having lived in rural environment, previous adobe housing) were analysed using SPSS 12.0 software (SPSS Inc, Chicago, IL). The chi-square test was applied to compare qualitative variables.
We performed a multivariate logistic regression. Depending variables were to have cardiac symptoms, and to present ECG or echocardiographic alterations; independent variables were age, sex, previous adobe housing and reported family or mother with T. cruzi infection.
Results were presented in terms of crude and adjusted (by age, sex and rural environment) odds ratios (OR) and 95% confidence intervals (95% CI). A tendency test compared ECG or echocardiographic alterations' presence with the Brazilian Consensus staging of cardiomyopathy. The p value was set at 0.05 for statistical significance.
Results
During the study period, 116 Latin American immigrants were newly-diagnosed with T. cruzi infection. Patients were excluded because of previous diagnosis or treatment of Chagas infection (8) , age under 15 years (2), concurrent cardiovascular diseases (2), pregnancy (4). One hundred patients remained in the study. The median age of the patients was 38.2 (SD= 10.2) years, 65 were female and the vast majority were from Bolivia. Socio-demographic and clinical characteristics are shown in Table 1 .
Overall, 41 patients had some ECG alteration at the moment of the diagnosis. The most common alteration was a single right bundle branch block (12 cases) which, combined with any other alteration, accounted for 18 of 41 abnormal ECG findings. Echocardiographic changes were seen in 31 patients, and allowed the diagnosis of Chagas cardiomyopathy in eight individuals with a normal ECG ( Table 2 ). The presence of ECG and echocardiogram alterations showed a significant association (p= 0.038). 
Discussion and conclusion
In our study of newly diagnosed Chagas disease patients, previous adobe housing was associated with presence of ECG alterations. This may be explained by the high probability of repetitive exposure of those living in adobe houses to triatomine bites with subsequent reinfections that can trigger autoimmune reaction and greater tissue damage [14] . In contrast with the majority of Chagas epidemiological studies, the presence of reported infection in the family and mother were associated with a decreased risk of ECG abnormalities. Several articles published, although not in a conclusive way, suggest the opposite. A familial aggregation could exist among Chagas cardiomyopathy cases due to a higher number of mother-to-child transmissions by highly infectious T. cruzi strains or due to a longer infection period [15, 16] . This fact could be explained by taking into account that the infected individual, usually asymptomatic and mainly with normal cardiac tests, was considered as "reference case" and a T. cruzi active research was done among close asymptomatic relatives. Of course, it was also carried out among patients with a beginning cardiac complication but, on the whole, family clustering tends to occur in chronic asymptomatic cases and overestimates their relationship with the asymptomatic stages of the disease. In our study, the presence of family and maternal history of Chagas infection relied on reported information from the patients; as relatives could not be serologically tested, this result should be interpreted cautiously. Overall, it likely represents a bias exemplifying the inherent shortcomings in studying a disease outside its own bio-geographic, endemic framework.
Factors consistently related in the literature to poor prognosis, such as age, male sex and multiple ECG alterations were not confirmed in our analysis. However, age is a risk factor for Chagas cardiomyopathy beyond any doubt [17, 18] , and it should be taken into account that in our small study group only 11 individuals were over 50 years old. Fourty-one of our patients showed some of ECG alterations, a far higher prevalence compared with that obtained in recent studies in other European countries such as Switzerland (11.3% [19] , France (23.6% [20] or even Barcelona urban area (19%) [21] . In contrast, it seems to follow a pattern similar to that described in studies carried out in endemic areas in South America: Northern Argentina (37.5%) [22] and Bolivia (50.8%) [23] . This may be explained by the origin of our study population. Nearly all patients came from rural highprevalence Bolivian environments, especially from Santa Cruz and Cochabamba Departments.
The prognosis of our patients is cause for concern. In one study carried out in rural Brazil, mortality over a six-year period was approximately 20% among infected persons with right bundle branch block [24] . Right bundle branch block was by far the most common ECG alteration in our sample (12 cases). Considering that the treatment given to patients, a 60-day course of benznidazol, could at best retard the progression of cardiac disease [25] , close clinical follow up and early identification of complications are crucial. They are the only realistic options with benefit for patients. However, close follow up remains a challenge due to the often great instability of migrant populations in terms of employment and housing.
The predominant echocardiographic abnormalities were alterations in left ventricular wall relaxation, usually to a moderate degree, as a likely reflection of the underlying fibrosis [26] . Unlike the ECG, echocardiography is a dynamic test that requires experience. Even in specialised centres, major disparities between echocardiographic features and post-mortem lesions have been described in Chagas disease patients [27] . However, we were able to identify with echocardiography eight of cardiac abnormalities that would not have been picked up through ECG results alone. This could be due to presence of very early fibroid lesions without ECG changes in a study population that was mainly in the early stages of heart disease.
Coherently with the outcomes of other studies [28, 29] , it may be reasoned that ECG and echocardiogram evaluate different aspects i.e. conduction system and structural-functional situation of the left ventricle, respectively of a specific cardiomyopathy in which left ventricular relaxation can be often identified as the earliest alteration [30] . Hence, both tests should be routinely carried out at the moment of diagnosis [31] .
The Brazilian Consensus classification of Chagas cardiomyopathy proved useful in categorising the cardiac function based on ECG or echocardiogram abnormalities. As in a recent Swiss study, it was considered as a suitable tool to staging Chagas cardiomyopathy in Europe [19] . The PAHO classification, however, may give a better idea of the Chagas disease burden at public health level as it clearly divides the infected population into those with and without pathological (clinical, ECG or echocardiographic) findings.
The central limitation of our study was the lack of patients in advanced stages of Chagas cardiomyopathy. Therefore, it was not possible to estimate the association between the severity of heart disease and the presence of concrete ECG or echocardiographic findings. Besides, the absence of a Latin American-migrant control group without Chagas disease makes it impossible to determine to what extent the described cardiac alterations are attributable to Chagas disease in Latin Americans. Moreover, the study population may not be fully representative of all Latin American migrants in the European Union or other non-endemic countries due to a possible under-representation of non-Bolivian or middle class patients. Patients assessed had been "filtered" by their family doctors and, therefore, they probably do not reflect exactly the clinical situation of Latin American patients in the community.
Our study results show that clinical, ECG and echocardiographic alterations coherent with Chagas cardiomyopathy were found in a large proportion of Latin American migrants with chronic Chagas disease. The majority were in early asymptomatic stages of the disease. Given these findings and the high number of migrants from endemic areas in our attendance area, Chagas disease might become an important cause of chronic cadiomyopathy in the mid-term in our attendance area. It should be considered in every Latin American patient with unexplained ECG abnormalities, cardiac symptoms or acute cardiovascular events. Chagas disease should no longer be perceived as an exotic disease. Due to its multiorgan, particularly cardiac manifestation, we recommend to involve a multidisciplinary collaborative patient management, including primary care physicians, cardiologists and tropical-medicine experts. Every effort directed towards identifying asymptomatic infected Latin American migrants should be encouraged st
